European Patent Office

T 2954/19 (Ulipristal acetate tablets / LABORATOIRE HRA) of 06.12.2022

European Case Law Identifier
ECLI:EP:BA:2022:T295419.20221206
Date of decision
6 December 2022
Case number
T 2954/19
Online on
12 December 2022
Petition for review of
-
Application number
09764855.4
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
ULIPRISTAL ACETATE TABLETS
Applicant name
Laboratoire HRA Pharma
Opponent name
Hexal AG
Helm AG
Cyndea Pharma. S.L.
Board
3.3.07
Headnote
-
Relevant legal provisions
Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal 2020 Art 025(2)European Patent Convention Art 100(a)European Patent Convention Art 56
Keywords
Late-filed evidence - admitted (yes)
Inventive step - Main request and auxiliary requests I to V (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

The appeal is dismissed.